These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17005112)

  • 1. Different additional risk factors for cerebral infarctions associated with the factor V Leiden mutation in a family.
    Vagiakou EA; Voudris KA; Dimitriou Y; Skardoutsou A; Mastroyianni S
    J Child Neurol; 2006 Oct; 21(10):903-7. PubMed ID: 17005112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTHFR homozygous mutation and additional risk factors for cerebral infarction in a large Italian family.
    Del Balzo F; Spalice A; Perla M; Properzi E; Iannetti P
    Pediatr Neurol; 2009 Jan; 40(1):63-7. PubMed ID: 19068258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular disorders in children with the factor V Leiden mutation.
    Lynch JK; Nelson KB; Curry CJ; Grether JK
    J Child Neurol; 2001 Oct; 16(10):735-44. PubMed ID: 11669347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral infarct associated with factor V Leiden mutation in a boy with hemophilia A.
    Olcay L; Gürgey A; Topaloglu H; Altay S; Parlak H; Firat M
    Am J Hematol; 1997 Nov; 56(3):189-90. PubMed ID: 9371534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral thalamic infarction in a patient with factor V Leiden mutation.
    Marinella MA; Greene K
    Mayo Clin Proc; 1999 Aug; 74(8):795-7. PubMed ID: 10473356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial thrombosis associated with factor V Leiden and methylenetetrahydrofolate reductase C677T mutation in childhood membranous glomerulonephritis.
    Büyükçelik M; Karakök M; Başpinar O; Balat A
    Pediatr Nephrol; 2008 Mar; 23(3):491-4. PubMed ID: 18030499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral infarction and femoral venous thrombosis detected in a patient with diabetic ketoacidosis and heterozygous factor V Leiden G1691A and PAI-1 4G/5G mutations.
    Yaroglu Kazanci S; Yesilbas O; Ersoy M; Kihtir HS; Yildirim HM; Sevketoglu E
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1183-6. PubMed ID: 25968433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebral apoplexy--anticardiolipin antibody and factor V Leiden mutation].
    Kirkeby R; Pedersen OD
    Ugeskr Laeger; 1997 Apr; 159(15):2233-5. PubMed ID: 9148550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factor V Leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarction.
    Haan J; Kappelle LJ; de Ronde H; Ferrari MD; Bertina RM
    Cephalalgia; 1997 Aug; 17(5):605-7. PubMed ID: 9251878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia: a risk factor for cerebral palsy?
    Yehezkely-Schildkraut V; Kutai M; Hugeirat Y; Levin C; Shalev SA; Mazor G; Koren A
    Isr Med Assoc J; 2005 Dec; 7(12):808-11. PubMed ID: 16382706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
    Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U
    N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
    Thorarensen O; Ryan S; Hunter J; Younkin DP
    Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical timing and presentation of periventricular haemorrhagic infarction in preterm infants: the role of thrombophilia.
    Harteman JC; Groenendaal F; van Haastert IC; Liem KD; Stroink H; Bierings MB; Huisman A; de Vries LS
    Dev Med Child Neurol; 2012 Feb; 54(2):140-7. PubMed ID: 22098125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of Factor V Leiden (G1691A) and Methylenetetrahydrofolate Reductase C677T Mutations in Sickle Cell Disease in Western India.
    Kangne HK; Jijina FF; Italia YM; Jain DL; Nadkarni AH; Ghosh KK; Colah RB
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):186-9. PubMed ID: 23869056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age.
    Rees DC; Liu YT; Cox MJ; Elliott P; Wainscoat JS
    Thromb Haemost; 1997 Nov; 78(5):1357-9. PubMed ID: 9408019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.